Skip to main content
. 2017 May 26;6:e25624. doi: 10.7554/eLife.25624

Figure 8. Regulation of β-lactamase by WhiB4 in a redox-dependent manner.

Oxidized (WhiB4-SS) and reduced (WhiB4-SH) forms of apo-WhiB4 were prepared. The concentrations of apo-WhiB4 used for EMSAs were 0.5, 1, 2, and 4 μM. EMSA reactions were performed with 0.5 nM 32P-labelled blaC (A), blaR (B) and whiB4 (C) promoter DNA fragments. C: DNA binding in the absence of WhiB4 in each panel. (D) Effect of WhiB4 on in vitro transcription. Single-round transcription assays show that RNAP-σA efficiently directs transcription from the blaC promoter. 100 nM of blaC promoter DNA fragment was pre-incubated with either 1 μM WhiB4-SS or WhiB4-SH and subjected to transcription by RNAP-σA as described in Materials and methods. C: blaC transcript in the absence of WhiB4. (E) 100 μg of cell-free lysates derived from exponentially grown (OD600 of 0.6) wt Mtb, MtbΔwhiB4 and whiB4-OE were used to hydrolyze nitrocefin. β-lactamase activity was measured by monitoring absorbance of hydrolyzed nitrocefin at 486 nm as described in Materials and methods. The fold change ratios clearly indicate a significantly higher or lower β-lactamase activity in MtbΔwhiB4 or whiB4-OE, respectively, as compared to wt Mtb. p-Values are shown for each comparison. (F) whiB4-OE strain was pre-treated with 5 mM of DTT or Diamide and β-lactamase activity in cell-free lysates was compared to MtbΔwhiB4 over time. *p≤0.05, **p≤0.01 and ***p≤0.001. Data are representative of at least two independent experiments done in duplicate.

DOI: http://dx.doi.org/10.7554/eLife.25624.023

Figure 8.

Figure 8—figure supplement 1. EMSA cold competition assay.

Figure 8—figure supplement 1.

(A) 0.5 μM of oxidized form of apo-WhiB4 (WhiB4-SS) was incubated with 0.5 nM 32P-labeled blaC and blaR promoter DNA fragments. Lanes 1 and 8: free probe; Lanes 2 and 9: WhiB4:blaC/blaR-promoter DNA complex. WhiB4 DNA binding was competed out using 10- (lanes 3 and 10), 25- (lanes 4 and 11), 50- (lanes 5 and 12), 100- (lanes 6 and 13), and 200- (lanes 7 and 14) fold molar excess of unlabeled competitor DNA, blaC and blaR. (B) Competition assay of 0.5 μM of WhiB4-SS binding using specific (blaC) and non-specific (Rv0986) promoter DNA fragments. Lane 1: 32P-labeled blaC DNA (free probe), Lane 2: WhiB4-SS:blaC-promoter DNA complex. WhiB4 DNA binding was competed using 100-fold molar excess of unlabeled blaC DNA (lane 3; specific) or Rv0986 DNA (lane 4; non-specific). (C) Competition assay of 0.5 μM of WhiB4-SS binding using specific (blaR) and non-specific (Rv0986) promoter DNA fragments. Lane 1: 32P-labeled blaR DNA (free probe), Lane 2: WhiB4-SS:blaR-promoter DNA complex. Competing unlabeled DNA fragments were either blaR DNA (lane 3; specific) or Rv0986 DNA (lane 4; non-specific), both used in 100-fold molar excess concentrations.